tinzaparin sodium
Sign in to saveantithrombotic drug in the heparin group
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Oligosaccharide
- First approval
- 2000
- Admin. routes
- parenteral
- Indications
- Recurrent thrombophlebitis, non-small cell lung carcinoma, deep vein thrombosis, Thromboembolism
via ChEMBL · EBI
Wikidata facts
- Image
- Syringe with Innohep 4500 Anti-Xa I.E.-7606.jpg
Show 2 more facts
- legal status (medicine)
- boxed warning
- Commons category
- Tinzaparin sodium
Sources (2)
via Wikidata · CC0